Literature DB >> 12893860

Pathophysiological insights from a case of reversible pulmonary arterial hypertension.

D Mukerjee1, E Kingdon, M Vanderpump, J G Coghlan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12893860      PMCID： PMC539573          DOI： 10.1177/014107680309600812

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  8 in total

Review 1.  Treatment of pulmonary hypertension secondary to connective tissue diseases.

Authors:  O Sanchez; M Humbert; O Sitbon; G Simonneau
Journal:  Thorax       Date:  1999-03       Impact factor: 9.139

2.  Growth factors in POEMS syndrome: evidence for a marked increase in circulating vascular endothelial growth factor.

Authors:  M Soubrier; J J Dubost; A F Serre; J M Ristori; B Sauvezie; P Cathebras; J C Piette; A Chapman; F J Authier; R K Gherardi
Journal:  Arthritis Rheum       Date:  1997-04

Review 3.  Reversible pulmonary hypertension in POEMS syndrome--another etiology of triggered pulmonary vasculopathy?

Authors:  G Paciocco; E Bossone; H Erba; M Rubenfire
Journal:  Can J Cardiol       Date:  2000-08       Impact factor: 5.223

4.  Pulmonary hypertension in POEMS syndrome: a new feature mediated by cytokines.

Authors:  P Lesprit; B Godeau; F J Authier; M Soubrier; M Zuber; C Larroche; J P Viard; B Wechsler; R Gherardi
Journal:  Am J Respir Crit Care Med       Date:  1998-03       Impact factor: 21.405

5.  Expression of vascular endothelial growth factor and its receptors correlates closely with formation of the plexiform lesion in human pulmonary hypertension.

Authors:  S Hirose; Y Hosoda; S Furuya; T Otsuki; E Ikeda
Journal:  Pathol Int       Date:  2000-06       Impact factor: 2.534

6.  The Crow-Fukase syndrome: a study of 102 cases in Japan.

Authors:  T Nakanishi; I Sobue; Y Toyokura; H Nishitani; Y Kuroiwa; E Satoyoshi; T Tsubaki; A Igata; Y Ozaki
Journal:  Neurology       Date:  1984-06       Impact factor: 9.910

7.  Plasma-cell dyscrasia with polyneuropathy. The spectrum of POEMS syndrome.

Authors:  G D Miralles; J R O'Fallon; N J Talley
Journal:  N Engl J Med       Date:  1992-12-31       Impact factor: 91.245

8.  Overproduction of proinflammatory cytokines imbalanced by their antagonists in POEMS syndrome.

Authors:  R K Gherardi; L Bélec; M Soubrier; D Malapert; M Zuber; J P Viard; L Intrator; J D Degos; F J Authier
Journal:  Blood       Date:  1996-02-15       Impact factor: 22.113
  8 in total
  2 in total

1.  Pulmonary morbidity improves after autologous stem cell transplantation in POEMS syndrome.

Authors:  Satish Chandrashekaran; Angela Dispenzieri; Stephen S Cha; Cassie C Kennedy
Journal:  Respir Med       Date:  2014-11-14       Impact factor: 3.415

2.  Severe Pulmonary Hypertension Caused by Smoldering Plasma Cell Myeloma: An Autopsy Case of POEMS Syndrome.

Authors:  Katsuya Chinen; Yasunori Fujioka
Journal:  Case Rep Med       Date:  2012-11-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.